HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas Schirbel Selected Research

Chemokine Receptors

11/2022Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET.
10/2022CXCR4 expression of multiple myeloma as a dynamic process: influence of therapeutic agents.
10/2022CXCR4-targeted theranostics in oncology.
6/2022C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma.
1/202268Ga-Pentixafor PET/CT for Detection of Chemokine Receptor CXCR4 Expression in Myeloproliferative Neoplasms.
1/2022Biokinetics and Dosimetry of 177Lu-Pentixather.
1/2020Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma.
1/2020Imaging Inflammation in Atherosclerosis with CXCR4-Directed 68Ga-Pentixafor PET/CT: Correlation with 18F-FDG PET/CT.
10/2019Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation.
1/2019Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell Lymphoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas Schirbel Research Topics

Disease

31Neoplasms (Cancer)
11/2022 - 06/2008
10Adrenocortical Carcinoma
11/2022 - 03/2012
10Neoplasm Metastasis (Metastasis)
01/2020 - 06/2008
8Multiple Myeloma
11/2022 - 04/2015
8Prostatic Neoplasms (Prostate Cancer)
10/2022 - 06/2015
6Hematologic Neoplasms (Hematological Malignancy)
11/2022 - 10/2019
4Adrenocortical Adenoma (Disease, Conn's)
11/2022 - 06/2008
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2022 - 02/2016
4Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2019 - 01/2014
3Lymphoma (Lymphomas)
10/2022 - 11/2018
3Sarcoidosis (Schaumann Disease)
01/2018 - 11/2016
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2022 - 10/2022
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2022 - 01/2019
2Adenoma (Adenomas)
01/2021 - 01/2018
2Inflammation (Inflammations)
01/2020 - 11/2016
2Leukemia
01/2019 - 01/2018
2Adenocarcinoma
01/2019 - 06/2008
1T-Cell Lymphoma (Lymphoma, T Cell)
06/2022
1Tumor Lysis Syndrome
06/2022
1Renal Insufficiency (Renal Failure)
06/2022
1Hypersensitivity (Allergy)
06/2022
1Pheochromocytoma
06/2022
1Primary Myelofibrosis (Myelosclerosis)
01/2022
1Polycythemia Vera
01/2022
1Essential Thrombocythemia
01/2022
1Adrenal Gland Neoplasms (Adrenal Cancer)
12/2021
1Squamous Cell Carcinoma of Head and Neck
11/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2021
1Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2021
1Pituitary Neoplasms (Pituitary Adenoma)
01/2021
1Cushing Syndrome
01/2021
1Smoldering Multiple Myeloma
08/2020
1Meningioma (Meningiomas)
05/2020
1Atherosclerotic Plaque (Atheroma)
01/2020
1Atherosclerosis
01/2020
1Renal Cell Carcinoma (Grawitz Tumor)
01/2019
1Acoustic Neuroma (Acoustic Neurinoma)
01/2019
1Hyperaldosteronism (Conn Syndrome)
01/2019
1Hepatocellular Carcinoma (Hepatoma)
01/2019
1Multiple Endocrine Neoplasia Type 2b (MEN 3)
01/2019
1Sepsis (Septicemia)
01/2019
1Ovarian Neoplasms (Ovarian Cancer)
01/2019
1Cholangiocarcinoma
01/2019
1Aspergillosis
01/2019
1Myocardial Infarction
10/2018
1Pain (Aches)
01/2018

Drug/Important Bio-Agent (IBA)

24Chemokine ReceptorsIBA
11/2022 - 04/2015
1768Ga-pentixaforIBA
11/2022 - 01/2016
8Radioisotopes (Radionuclides)IBA
01/2021 - 03/2012
7Peptide Receptors (Peptide Receptor)IBA
01/2021 - 01/2014
6AntigensIBA
10/2022 - 06/2015
6Somatostatin Receptors (Somatostatin Receptor)IBA
05/2020 - 04/2014
5LigandsIBA
10/2022 - 02/2016
4Proteins (Proteins, Gene)FDA Link
05/2022 - 05/2009
4iodophenyl metomidateIBA
12/2021 - 06/2008
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2021 - 01/2020
4gallium 68 PSMA-11IBA
11/2020 - 06/2015
3Edotreotide (SMT 487)IBA
06/2022 - 04/2014
3Mitotane (Lysodren)FDA Link
03/2016 - 11/2015
23-Iodobenzylguanidine (Iobenguane)IBA
06/2022 - 05/2009
2Biomarkers (Surrogate Marker)IBA
06/2022 - 05/2020
2CXCR ReceptorsIBA
10/2019 - 01/2018
2LipidsIBA
11/2015 - 09/2015
1N 30IBA
11/2022
1Indicators and Reagents (Reagents)IBA
10/2022
1Adenosine Monophosphate (AMP)IBA
10/2022
1Dihydroxyphenylalanine (Dopa)IBA
06/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1Urea (Carbamide)FDA LinkGeneric
01/2022
190Y-pentixatherIBA
01/2022
1PSMA-617IBA
01/2022
1Mixed Function Oxygenases (Monooxygenases)IBA
01/2022
1PSMA I&TIBA
01/2022
1Lutetium-177IBA
01/2022
1Carboxylic AcidsIBA
12/2021
1imidazoleIBA
12/2021
11- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
11/2021
11,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
11/2021
1Peptides (Polypeptides)IBA
11/2021
1CD13 Antigens (Alanine Aminopeptidase)IBA
11/2021
1Ubiquitin-Specific ProteasesIBA
01/2021
1CateninsIBA
01/2021
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2021
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2021
1Adrenocorticotropic Hormone (ACTH)FDA Link
01/2021
1AndrogensIBA
11/2020
1Biological ProductsIBA
01/2020
1Gallium-68IBA
01/2020
168Ga-DOTAGA-(3-iodo-y)fk(Sub-KuE)IBA
01/2020
1AldosteroneIBA
01/2018

Therapy/Procedure

23Therapeutics
10/2022 - 03/2012
8Precision Medicine
10/2022 - 01/2017
5Drug Therapy (Chemotherapy)
01/2022 - 02/2016
4Hematopoietic Stem Cell Transplantation
10/2022 - 01/2018
4Radiotherapy
05/2020 - 02/2016
3Stem Cell Transplantation
01/2022 - 02/2016
2Castration
10/2022 - 01/2022
1Lymph Node Excision (Lymph Node Dissection)
11/2021
1Adrenalectomy
01/2021
1Radioimmunotherapy
01/2019